A key focus of research on pancreatic ductal adenocarcinoma (PDAC) is identifying new techniques to tailor gemcitabine and 5-fluorouracil treatments. Availability of tumor tissue is critical for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback